Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Christian Sirrenberg, Darmstadt DE

Christian Sirrenberg, Darmstadt DE

Patent application numberDescriptionPublished
20090131506Oxindoles as Kinase Inhibitors - The present invention relates to oxindoles of the formula I, their use as protein kinase activators or inhibitors, a method for their manufacture, their use for the preparation of a medicament for the treatment of diseases and their use for the manufacture of a pharmaceutical composition.05-21-2009
20090163556GLYCINAMIDE DERIVATIVES AS RAF-KINASE INHBITORS - The present invention relates to glycinamide derivatives of formula I,06-25-2009
20090197882INDAZOLE DERIVATIVES FOR THE TREATMENT OF HSP90-INDUCED DISEASES - Novel indazole derivatives of the formula (I), in which R08-06-2009
20090253688Semicarbazide derivatives as kinase inhibitors - The present invention relates to semicarbazide derivatives of formula I, the use of the compounds of formula I as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.10-08-2009
20090298885METHYLENE UREA DERIVATIVES - The present invention relates to methylene urea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.12-03-2009
200903259741,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS - Novel 1,5-diphenylpyrazole derivatives of the formula (I) in which R12-31-2009
20100022540TRIAZOLE DERIVATIVES II - Novel triazole derivatives of the formula (I) in which R01-28-2010
20100113542TRIAZOLE DERIVATIVE AS AN HSP 90 INHIBITOR - 5-[4-(2-Methylphenyl)-3-hydroxy-4H-1,2,4-triazol-5-yl]-2,4-dihydroxy-N-methyl-N-butylbenzamide is an HSP90 inhibitor and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.05-06-2010
201001739234 (PYRROLOPYRIDINYL)PYRIMIDINYL-2-AMINE DERIVATIVES - Compounds of the formula I in which R07-08-2010
20100197757OXINDOLES AS KINASE INHIBITORS - The present invention relates to oxindoles of the formula I, their use as protein kinase activators or inhibitors, a method for their manufacture, their use for the preparation of a medicament for the treatment of diseases and their use for the manufacture of a pharmaceutical composition.08-05-2010
20100234324Quinazolinamide derivatives - Novel quinazolinamide derivatives of the formula (I), in which R09-16-2010
201002922624 (PYRROLO[2,3-C]PYRIDINE-3-YL)PYRIMIDIN-2-AMINE DERIVATIVES - Compounds of the formula (I), in which R11-18-2010
201100284851,5-DIPHENYLPYRAZOLES II AS HSP90 INHIBITORS - Novel 1,5-diphenylpyrazole derivatives of the formula (I) in which R02-03-2011
201100821406-(PYRROLOPYRIDINYL) PYRIMIDIN-2-YLAMINE DERIVATIVES AND THE USE THEREOF FOR THE TREATMENT OF CANCER AND AIDS. - Compounds of the formula (I), in which R04-07-2011
201100925274 (Pyrrolopyridinyl)pyrimidin-2-ylamine derivatives - Compounds of the formula (I), in which R04-21-2011
20110136830CHROMENONE DERIVATIVES - Novel compounds of the formula I06-09-2011

Patent applications by Christian Sirrenberg, Darmstadt DE